A lipopeptide with enzyme inhibitory and immunosuppressant activities
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Plipastatin A1

Item No. 38916

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
(10→3)-lactone, N-[(3R)-3-hydroxy-1-oxohexadecyl]-L-α-glutamyl-D-ornithyl-L-tyrosyl-D-allothreonyl-L-α-glutamyl-prolyl-L-glutaminyl-D-tyrosyl-L-isoleucine
CAS Number
103651-09-8
Synonyms
  • Fengycin IX
  • SNA-60-367-3
Molecular Formula
C72H110N12O20
Formula Weight
1463.7
Purity
≥90%
Formulation (Request formulation change)
A solid
Solubility(Learn about Variance in Solubility)
DMSO: SolubleMethanol: SolubleWater: Soluble
SMILES
O=C([C@H](NC([C@@H](NC(C[C@@H](CCCCCCCCCCCCC)O)=O)CCC(O)=O)=O)CCCN)N[C@@H](CC1=CC=C(OC([C@@]([C@@H](C)CC)([H])NC([C@@H](CC2=CC=C(O)C=C2)NC3=O)=O)=O)C=C1)C(N[C@@]([C@H](O)C)([H])C(N[C@@H](CCC(O)=O)C(N[C@H](C)C(N4[C@@](C(N[C@H]3CCC(N)=O)=O)([H])CCC4)=O)=O)=O)=O
InChi Code
InChI=1S/C72H110N12O20/c1-6-8-9-10-11-12-13-14-15-16-17-20-48(87)41-58(89)76-51(32-35-59(90)91)65(96)77-50(21-18-37-73)64(95)80-55-40-46-25-29-49(30-26-46)104-72(103)61(42(3)7-2)82-67(98)54(39-45-23-27-47(86)28-24-45)81-66(97)52(31-34-57(74)88)78-69(100)56-22-19-38-84(56)71(102)43(4)75-63(94)53(33-36-60(92)93)79-70(101)62(44(5)85)83-68(55)99/h23-30,42-44,48,50-56,61-62,85-87H,6-22,31-41,73H2,1-5H3,(H2,74,88)(H,75,94)(H,76,89)(H,77,96)(H,78,100)(H,79,101)(H,80,95)(H,81,97)(H,82,98)(H,83,99)(H,90,91)(H,92,93)/t42-,43+,44+,48+,50+,51-,52-,53-,54+,55-,56-,61-,62+/m0/s1
InChi Key
CUOJDWBMJMRDHN-VIHUIGFUSA-N
Origin
Bacterium/Bacillus sp.
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $516

    Add
    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    Plipastatin A1 is a lipopeptide that has been found in B. cereus and has enzyme inhibitory and immunosuppressant activities.1 It inhibits phospholipase A2 (PLA2), PLC, and PLD (IC50s = 2.9, 1.3, and 1.4 µM, respectively). Plipastatin A1 (100 µg/ml) inhibits LPS-induced B cell blastogenesis and T cell blastogenesis induced by concanavalin A (Item No. 14951). In vivo, plipastatin A1 (0.1 mg/animal) inhibits delayed-type hypersensitivity in mice.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Umezawa, H., Ayoagi, T., Nishikiori, T., et al. Plipastatins: New inhibitors of phospholipase A2, produced by Bacillus cereus BMG302-fF67. I. Taxonomy, production, isolation and preliminary characterization. J. Antibiot. (Tokyo) 39(6), 737-744 (1986).